Multiple Myeloma
What's New
Last Posted: Sep 18, 2023
- Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma
SM Setayesh et al, NPJ Prec Oncol September 18, 2023 - Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance.
Alexander J Ryu et al. Blood cancer journal 2023 13(1) 28 - MGP Panel is a comprehensive targeted genomics panel for molecular profiling of multiple myeloma patients.
Sudha Parvathi et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 - Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.
Alaterre Elina et al. Theranostics 2022 12(4) 1715-1729 - Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma; A population-based study.
Langseth Øystein O et al. European journal of haematology 2022 - Impact of Omicron variant on the response to SARS-CoV-2 mRNA vaccination in multiple myeloma and monoclonal gammopathies
P Storti et al, MEDRXIV, February 26, 2022 - Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection.
Allegra Alessandro et al. Cancers 2022 14(3) - A polygenic risk score for multiple myeloma risk prediction.
Canzian Federico et al. European journal of human genetics : EJHG 2021 11 - High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.
Coffey David G et al. JCO precision oncology 2021 5 - Single-cell RNA sequencing: one step closer to the clinic- Single-cell RNA-sequencing can help in the prediction of drug resistance in patients with multiple myeloma
RS Pistofidis et al, Nature Medicine, March 4, 2021
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: